Skip to main content
Log in

Actualités en cancérologie digestive à l’UEGW 2016

Latest news in digestive oncology at UEGW 2016

  • Comptes-Rendus de Congrès / Congresses, Conferences
  • Published:
Acta Endoscopica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Références

  1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9–29.

    Article  PubMed  Google Scholar 

  2. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/.

  3. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. NEJM 2014;371:1039–49.

    Article  CAS  PubMed  Google Scholar 

  4. Conroy T, Desseigne F, Ychou M, et al. Folfirinox vs gemcitabine for metastatic pancreatic cancer. NEJM 2011;364:1817–25.

    Article  CAS  PubMed  Google Scholar 

  5. Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. NEJM 2013;369:1691–703.

    Article  Google Scholar 

  6. Ducreux M, Cuhna AS, Caramella C, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26:v56–v68.

    Article  PubMed  Google Scholar 

  7. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005;33:223–31.

    Article  CAS  PubMed  Google Scholar 

  8. Paiella S, Butturini G, Frigerio I, et al. Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study. Dig Surg 2015;32:90–7.

    Article  PubMed  Google Scholar 

  9. Tasu JP, Vesselle G, Herpe G, et al. Irreversible electroporation for locally advanced pancreatic cancer. Diagn Interv Imaging 2016;97:1297–304.

    Article  PubMed  Google Scholar 

  10. Vogel A, Rombots, De Rooijet T, et al. Multimodality treatment of locally advanced pancreatic cancer, including Folfirinox chemotherapy, surgical exploration and irreversible electroporation: prospective series of 132 consecutive patients. UEGW Journal 2016,4:A130.

    Google Scholar 

  11. de Wilde RF, Besselink MG, van der Tweel I, et al. Impact of nationwide centralization of pancreaticoduodenectomy on hospitalcmortality. Br J Surg 2012;99:404–10.

    Article  PubMed  Google Scholar 

  12. Van Hilst J, Walma MS, Vogel JA, et al. Nationwide multidisciplinary online expert panel for pancreatic cancer: initial results. UEGW Journal 2016,4:A131.

    Google Scholar 

  13. TNCD: http://www.tncd.org.

  14. Stöß C, Nitsche U, Stecher L, et al. Primary tumor resection in metastasized colorectal cancer — A meta-analysis. UEGW Journal 2016,4:A471.

    Google Scholar 

  15. Ngamruengphong S, Kamal A, Hajiyeva G, et al. Prevalence of lymph node metastasis and long term survival of T1 rectal carcinoid tumors: an analysis of surveillance, epidemiology, and end results (SEER) database. UEGW Journal 2016,4:A107.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Lecomte.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lecomte, T., Vaillant, E. Actualités en cancérologie digestive à l’UEGW 2016. Acta Endosc 47, 36–38 (2017). https://doi.org/10.1007/s10190-017-0582-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10190-017-0582-x

Navigation